1 – 10 of 178
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin
(
- Contribution to journal › Article
- 2023
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
(
- Contribution to journal › Article
-
Mark
Assessment of a hand-held CZT-based gamma camera for pre-clinical imaging of 177Lu
2023) 2023 IEEE Nuclear Science Symposium and Medical Imaging Conference(
- Contribution to conference › Poster
-
Mark
Investigation of a CZT-based hand-held gamma-camera for pre-clinical imaging of alpha-emitter 225Ac
2023) Annual Congress of the European Association of Nuclear Medicine In European Journal of Nuclear Medicine and Molecular Imaging 50(Suppl 1). p.129-129(
- Contribution to journal › Published meeting abstract
-
Mark
Tumor Control Probability and Small-Scale Monte Carlo Dosimetry : Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy
(
- Contribution to journal › Article
- 2022
-
Mark
Small-scale dosimetry for alpha particle 241Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3
(
- Contribution to journal › Article
-
Mark
Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617
(
- Contribution to journal › Article
-
Mark
A 3D-printed mouse phantom for the evaluation of a hand-held CZT-based gamma camera
2022) 2022 Höstmöte för Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi(
- Contribution to conference › Abstract
- 2021
-
Mark
Humanization, radiolabeling and biodistribution studies of an igg1-type antibody targeting uncomplexed psa for theranostic applications
(
- Contribution to journal › Article
-
Mark
PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
(
- Contribution to journal › Article